Where there is neurological involvement, the loading phase uses alternate-day injections until there is no further improvement, and maintenance is 1 mg every two months
Additionally, findings suggested that DA transporter availability was lower in the exenatide group compared to the placebo group, potentially indicating altered DA dynamics associated with reduced cravings and cue sensitivity (Zhang et al., 2019)
There are only 3 medications approved by the US Food and Drug Administration (FDA) to treat AUD: disulfiram, naltrexone, and acamprosate and they have poor compliance
EASES GLP-1 SIDE EFFECTS: Dietary beverage helps reduce common adverse gastrointestinal reactions to GLP-1 prescriptions such as nausea, constipation, bloating, diarrhea, and fatigue
The evidence is pretty clear on this: a lot of patients regain weight when they come off GLP-1 therapy
An open-label, single-arm pilot study involving 21 patients, evaluated the effect of 3,000 mg ALC daily on the intra-epidermal nerve fiber (IENF) density and mitochondrial DNA (mtDNA) copies/cell